wt1 peptide-pulsed dendritic cells
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 22, 2008 (NCT00923910)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous wt1 mrna-loaded dcs
- wt1 peptide-pulsed dendritic cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02649829 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2015 | University of Antwerp |
| NCT00923910 | Phase 1/Phase 2 (Phase 2) | Feb 22, 2008 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2008 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2008 |
| University of Antwerp | Academic/Hospital | 1 | 1 | 1 | 2015 |
3 organizations
Page 1 / 1